Ozempic vs Wegovy vs Zepbound: The Differences Explained
Four brand names, two medications. Here is the simple version of what is in each, what each is approved for, and how the active ingredients compare.
The short answer
Four brand names, two medications. Ozempic and Wegovy are distinct FDA-approved brand products that contain semaglutide. Mounjaro and Zepbound are distinct FDA-approved brand products that contain tirzepatide. The difference within each pair is mainly what the brand is approved for (type 2 diabetes versus weight management) and the dosing. So the real comparison is not Ozempic versus Wegovy, it is semaglutide versus tirzepatide.
Quick comparison
| Feature | Ozempic | Wegovy | Zepbound |
|---|---|---|---|
| Active ingredient | Semaglutide | Semaglutide | Tirzepatide |
| Maker | Novo Nordisk | Novo Nordisk | Eli Lilly |
| FDA-approved for | Type 2 diabetes | Chronic weight management | Chronic weight management |
| How it is taken | Injection | Injection | Injection |
| Appetite pathways | GLP-1, one pathway | GLP-1, one pathway | GLP-1 and GIP, two pathways |
| Average weight loss in trials | About 15 percent (semaglutide) | About 15 percent (semaglutide) | About 20 percent or more at top doses |
| At New Hope Weight Loss | Compounded semaglutide offered, not the same as this brand-name product | Compounded semaglutide offered, not the same as this brand-name product | Compounded tirzepatide offered, not the same as this brand-name product |
The semaglutide pair: Ozempic and Wegovy
Ozempic® and Wegovy® are different FDA-approved products that contain semaglutide. Ozempic is approved for specific type 2 diabetes-related indications; Wegovy has different indications and dosing, including chronic weight management. Sharing an ingredient name does not make the products or their labels interchangeable.
Ready to start?
$199 Skeptics' Trial, see if it works for you
One-time $199 trial with physician evaluation and, only if a prescription is approved and the dispensing pharmacy can fulfill it for the patient's location, one month of compounded semaglutide; the pharmacy confirms packaging and shipping details before fulfillment. No long-term commitment. Standard care starts with a $119 physician review; medication is separate, and compounded semaglutide programs start at $166/month.
Start the 30-day trialThe tirzepatide pair: Mounjaro and Zepbound
Both contain tirzepatide and act on two pathways, GLP-1 and GIP. Mounjaro® is approved for type 2 diabetes; Zepbound® is the version approved for chronic weight management. The dual-action mechanism is why tirzepatide tends to produce greater average weight loss than semaglutide in studies.
Semaglutide versus tirzepatide, simply
- Mechanism. Semaglutide acts on one pathway (GLP-1); tirzepatide acts on two (GLP-1 and GIP).
- Average results. Semaglutide commonly produces around 15 percent body-weight loss in trials; tirzepatide often around 20 percent or more at the top doses.
- Approved use. Each ingredient has a diabetes brand and a weight-management brand.
- Right choice. Depends on your health, tolerance, goals, and what your physician recommends, not only the average number.
Where compounded options fit
You may also hear about compounded semaglutide or tirzepatide. That is a separate topic with its own considerations around access, cost, and sourcing, and it is covered in its own article. Compounded medication is not the same as a brand-name product, and any responsible program is transparent about what it provides.
The bottom line
If you are comparing Ozempic, Wegovy, Zepbound, and Mounjaro, start by grouping them: two are semaglutide, two are tirzepatide. Then the meaningful question is which active ingredient and dose fit you, which is a medical decision made with a physician based on your full health picture.
Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with, endorsed by, or sponsored by these companies. Compounded semaglutide and compounded tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality.
Compare products, not ingredient names
Use each current FDA label to compare indication, dose form, schedule, contraindications, warnings, evidence, and manufacturer instructions. Similar ingredient names do not make products interchangeable or establish equal outcomes.
Frequently asked questions
What is the difference between Ozempic and Wegovy?
Both are FDA-approved brand products that contain semaglutide. The difference is the approved use and dosing: Ozempic is approved for type 2 diabetes, while Wegovy is the version approved for chronic weight management and goes up to a higher dose for that purpose. Because the ingredient is the same, people often hear the names used interchangeably, but they are branded for different primary uses.
What is the difference between Zepbound and Mounjaro?
Both are FDA-approved brand products that contain tirzepatide, which acts on two appetite pathways. Mounjaro is approved for type 2 diabetes, and Zepbound is the version approved for chronic weight management. As with Ozempic and Wegovy, the active ingredient is identical; the difference is the approved use and dosing.
Is Ozempic or Zepbound better for weight loss?
Zepbound contains tirzepatide, which acts on two pathways and tends to produce greater average weight loss in studies than semaglutide (the ingredient in Ozempic and Wegovy). That said, the right choice depends on your health, tolerance, and goals, not only the average. For weight management specifically, the semaglutide brand to compare is Wegovy rather than Ozempic.
Are Ozempic and Wegovy the same drug?
Yes. Both are semaglutide. The difference is the approved indication and dosing, not the active ingredient. Ozempic is approved for type 2 diabetes and Wegovy for chronic weight management, with Wegovy going up to a higher dose for weight loss. A physician determines which is appropriate for you.
Which GLP-1 should I take?
That is a medical decision. It depends on your health history, tolerance, goals, other medications, and what your physician recommends, not just the headline number. The active ingredient (semaglutide versus tirzepatide) and physician supervision matter far more than the brand name, and availability of specific brands can change over time.
This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.